February 12, 2020February 12, 2020
Phase 1/2 Trial of ‘Off-the-shelf’ CAR T-cell Therapy for Multiple Myeloma to Open Soon
News
A clinical trial is soon to begin testing Precision BioSciences‘s new CAR T-cell therapy candidate, PBCAR269A, in people with relapsed or ... Read more
February 11, 2020February 14, 2020
FDA Asked to Approve Darzalex Triple Combo for Relapsed or Refractory Multiple Myeloma
News
Janssen has asked the U.S. Food and Drug Administration (FDA) to allow Darzalex (daratumumab) to also be used in combination with Kyprolis ... Read more
February 10, 2020February 10, 2020
Antibiotics Prevent Fevers, Death in Newly Diagnosed Myeloma Patients, Study Says
News
Preventive treatment with the antibiotic levofloxacin can lower the incidence of fever and death in people newly diagnosed with ... Read more
February 7, 2020February 7, 2020
Advancing Novel Cell Therapy for Myeloma and Multiple Cancers Goal of New Partnership
News
A recent partnership between Indapta Therapeutics and Lonza is advancing the development of an off-the-shelf cell therapy designed to treat ... Read more
February 5, 2020
EMA Reviewing Belantamab Mafodotin for Heavily Pretreated Multiple Myeloma
News
The European Medicines Agency has agreed to review the application of GlaxoSmithKline‘s belantamab mafodotin for the treatment of heavily treated multiple myeloma patients, ... Read more
February 3, 2020February 3, 2020
Takeda, Snow Myeloma App ‘Being Patient’ Wins Pharma Choice Award
News
Takeda and Snow Companies won one of the top prizes in PM360’s annual Pharma Choice Awards for an app ... Read more
January 31, 2020January 31, 2020
Researchers Provide Highlights on Study into Benefits of Reolysin, Kyprolis Combo in Multiple Myeloma
News
Researchers are continuing to study how the combination of Oncolytics Biotech‘s virus-based anti-cancer therapy Reolysin (pelareorep) and Kyprolis (carfilzomib) provides benefits ... Read more
January 29, 2020January 29, 2020
Allogene, SpringWorks Collaborate to Test ALLO-715, Nirogacestat Combo for RRMM
News
Allogene Therapeutics and SpringWorks Therapeutics have launched a clinical trial collaboration to conduct a Phase 1 study assessing an ... Read more
January 27, 2020January 27, 2020
Sanofi Partners to Develop Diagnostic Test for Multiple Myeloma Patients on Potential Therapy
News
Sanofi announced that it partnered with Sebia to develop a new multiple myeloma diagnostic test that will help to mitigate the interference ... Read more
January 24, 2020January 24, 2020
FDA Grants Priority Review to Belantamab Mafodotin for Heavily-treated Multiple Myeloma
News
The U.S. Food and Drug Administration (FDA) has granted priority review status to GlaxoSmithKline‘s application seeking the approval of belantamab mafodotin for the ... Read more
January 21, 2020January 22, 2020
Darzalex Combo Approved in Europe to Treat Transplant-eligible Myeloma Patients
News
The European Commission has approved Darzalex (daratumumab), in combination with standard pre-transplant therapy, to treat newly diagnosed multiple myeloma patients who are eligible for autologous ... Read more
January 20, 2020January 20, 2020
NexImmune to Initiate Phase 1/2 Trial of NEXI-002 Cell Therapy for RRMM Patients
News
NexImmune will soon initiate a Phase 1/2 trial evaluating its cell therapy NEXI-002 in people with multiple myeloma who ... Read more

$FDA Asked to Approve Darzalex Triple Combo for Relapsed or Refractory Multiple Myeloma$

February 12, 2020February 12, 2020

Phase 1/2 Trial of ‘Off-the-shelf’ CAR T-cell Therapy for Multiple Myeloma to Open Soon

News

A clinical trial is soon to begin testing Precision BioSciences‘s new CAR T-cell therapy candidate, PBCAR269A, in people with relapsed or refractory multiple myeloma. The Phase 1/2a trial (NCT04171843) is expected to begin ... Read more

$FDA Asked to Approve Darzalex Triple Combo for Relapsed or Refractory Multiple Myeloma$

February 11, 2020February 14, 2020

FDA Asked to Approve Darzalex Triple Combo for Relapsed or Refractory Multiple Myeloma

News

Janssen has asked the U.S. Food and Drug Administration (FDA) to allow Darzalex (daratumumab) to also be used in combination with Kyprolis (carfilzomib) and dexamethasone to treat people with relapsed or refractory multiple myeloma ... Read more

February 10, 2020February 10, 2020

Antibiotics Prevent Fevers, Death in Newly Diagnosed Myeloma Patients, Study Says

News

Preventive treatment with the antibiotic levofloxacin can lower the incidence of fever and death in people newly diagnosed with multiple myeloma, results from a Phase 3 clinical trial suggest. ... Read more

February 7, 2020February 7, 2020

Advancing Novel Cell Therapy for Myeloma and Multiple Cancers Goal of New Partnership

News

A recent partnership between Indapta Therapeutics and Lonza is advancing the development of an off-the-shelf cell therapy designed to treat multiple types of cancers, including multiple myeloma, the companies announced. The ... Read more

February 5, 2020

EMA Reviewing Belantamab Mafodotin for Heavily Pretreated Multiple Myeloma

News

The European Medicines Agency has agreed to review the application of GlaxoSmithKline‘s belantamab mafodotin for the treatment of heavily treated multiple myeloma patients, the company announced in a press release. Specifically, the marketing authorization ... Read more

February 3, 2020February 3, 2020

Takeda, Snow Myeloma App ‘Being Patient’ Wins Pharma Choice Award

News

Takeda and Snow Companies won one of the top prizes in PM360’s annual Pharma Choice Awards for an app aimed at promoting understanding of what life with multiple myeloma is ... Read more

January 31, 2020January 31, 2020

Researchers Provide Highlights on Study into Benefits of Reolysin, Kyprolis Combo in Multiple Myeloma

News

Researchers are continuing to study how the combination of Oncolytics Biotech‘s virus-based anti-cancer therapy Reolysin (pelareorep) and Kyprolis (carfilzomib) provides benefits in multiple myeloma patients, according to a recent conference call. ... Read more

January 29, 2020January 29, 2020

Allogene, SpringWorks Collaborate to Test ALLO-715, Nirogacestat Combo for RRMM

News

Allogene Therapeutics and SpringWorks Therapeutics have launched a clinical trial collaboration to conduct a Phase 1 study assessing an ALLO-715 combination therapy in people with relapsed or refractory multiple ... Read more

January 27, 2020January 27, 2020

Sanofi Partners to Develop Diagnostic Test for Multiple Myeloma Patients on Potential Therapy

News

Sanofi announced that it partnered with Sebia to develop a new multiple myeloma diagnostic test that will help to mitigate the interference of isatuximab when measuring levels of monoclonal protein — a marker ... Read more

January 24, 2020January 24, 2020

FDA Grants Priority Review to Belantamab Mafodotin for Heavily-treated Multiple Myeloma

News

The U.S. Food and Drug Administration (FDA) has granted priority review status to GlaxoSmithKline‘s application seeking the approval of belantamab mafodotin for the treatment of heavily treated multiple myeloma patients, the company announced ... Read more